Abstract
The artificial endocrine pancreas is a feedback controlled instrument regulating insulin delivery on a minuteby-minute basis according to measured blood glucose levels. It has been proven to be useful not only as the therapeutic tool of diabetes mellitus but also as an elegant research tool for investigating the pathophysiology of the disease.
The wearable type of closed-loop system has been developed recently for the first time by the authors. The breakthrough is the establishment of needle-type glucose sensor.
The trend in development of closed-loop glycemic control system which enables perfectly physiological regulation on long-term basis, is directed to implantable devices. Much efforts have been conducted now to realize these devices.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, Schipper H, Gander R: Clinical control of diabetes by the artificial pancreas. Diabetes 23: 397–404, 1974.
Bartlett D Jr, Tenney SM: Tissue gas tensions in experimental anemia. J Appl Physiol 18: 734–8, 1963.
Gibson QH, Swoboda BEP, Massey V: Kinetics and mechanism of action of glucose oxidase. J Biol Chem 239: 392–734, 1964.
Goriya Y, Kawamori R, Shichiri M, Abe H: The development of an artificial beta cell system and its validation in depancreatized dogs: The physiological restoration of blood glucose homeostasis. Med Prog Technol 6: 99–108, 1979.
Ikeda S, Sawafa Y, Mino K, Ishida M, Ito K, Ichikawa K, Yukawa M, Ichihashi H, Kondo T: Improvement of membranes for glucose sensor. Jpn J Artif Organ 11: 992–5, 1982.
Kawamori R, Shichiri M, Goriya Y, Yamasaki Y, Shigeta Y, Abe H: Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell. Acta Endocrinol 87: 339–51, 1978.
Kawamori R, Shichiri M, Kikuchi M, Yamasaki Y, Abe H: Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta cell. Diabetes 29: 762–765, 1980.
Kawamori R, Yamasaki Y, Murata T, Morishima T, Yagi T, Goriya Y, Shichiri M, Abe H: Validation of self-adaptive control algorithm for blood glucose concentration in artificial beta cell. Automedica 3: 183–9, 1980.
Pfeiffer EF, Thum Ch, Clemens AH: The artificial beta-cell: A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 6: 339–42, 1974.
Schlichtkrull J, Munk O, Jersild M: The M-value, an index of blood-sugar control in diabetes. Acta Med Scand 177: 95–102, 1965.
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644–755, 1970.
Sherman C, Delay BDT, Clay W, Desse K: In vivo evaluations of transcutaneous energy transmission (TET) system. Trans Am Soc Artif Intern Organs 30: 143–50, 1984.
Shichiri M, Kawamori R, Abe H: Normalization of paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 28: 272–5. 1979.
Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H: Wearable-type artificial endocrine pancreas with needle-type glucose sensor. Lancet 2: 1129–31, 1982.
Shichiri M, Kawamori R, Goriya Y, Yamasaki Y, Hakui N, Asakawa N, Abe H: Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas. Diabetologia 24: 179–84, 1983.
Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H: Closed-loop glycemic control with a wearable artificial endocrine pancreas–Validations in daily insulin requirements to glycemic response. Diabetes 33: 1200–1202, 1984.
Shichiri M, Asakawa N, Yamasaki Y, Kawamori R, Abe H: Telemetry Glucose monitoring device with needle-type glucose sensor: A useful tool for blood glucose monitoring in diabetic individuals. Diabetes Care 9: 298–301, 1986.
Williams D, Doig A, Korosi A: Electrochemical enzymatic analysis of blood glucose and lactate. Anal Chem 42: 118–21, 1970.
Woodward SC: How fibroblasts and giant cells encapsulate implants: Considerations in design of glucose sensors. Diabetes Care 5: 278–281, 1982.
Yamasaki Y, Shichiri M, Kawamori R, Goriya Y, Sasai T, Morishima T, Nomura M, Tohdo R, Abe H: Counter-regulatory system in an artificial endocrine pancreas–Glucose infusion algorithm. Artif Organs 3: 265–70, 1979.
Yamasaki Y: The development of a needle-type glucose sensor for wearable artificial endocrine pancreas. Med J Osaka Univ 35: 25–34, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Shichiri, M., Kawamori, R., Yamasaki, Y. (1987). The development of artificial endocrine pancreas. In: Atsumi, K., Kajiya, F., Tsuji, T., Tsujioka, K. (eds) Medical Progress through Technology. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3361-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-3361-3_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-89838-973-9
Online ISBN: 978-94-009-3361-3
eBook Packages: Springer Book Archive